Great post! I think it's great to hear from someone who has been investing in this company for a while. I myself am a newcomer, but the news and GK's aura of confidence have made me a firm believer. While I do not believe that every single one of their products is sure to be a hit, I do believe in the potential of their platform to produce, sooner or later, one or more outstanding treatments for currently hard-to-treat diseases.
I, too, was interested in the treatment that GK had supposedly given himself and thus looked into it a bit. While I didn't find any definitive information (and I'm not sure if I read it from an official source or a post from someone on a message board), it seemed as though he had injected himself with one of their prototypes when he was struggling with prostate cancer himself. However, he had also undergone chemotherapy (or was it surgery?) and radiation in addition to the self-administered injections, so it can be difficult to know how much and how well each part of the treatment contributed to his current state of wellbeing. However, at the very least, he doesn't seem like he poisoned himself, so this would seem to hint at the treatment being safe and nontoxic, which would then be promising for successful completion of a phase I trial, as that is mostly concerned with how toxic it is and not how effective it is as a treatment. I believe GK did mention that the drug he injected was an earlier prototype and was something like "1000 times" less potent than the current candidates, though.
I wish you the best, and there certainly may be some stumbles left before this company hits a SP of $50, but I think it's coming, maybe as soon as the next 5-10 years.
NRT Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
